558: Founder of McKinsey's Strategy and Corporate Finance Insights Team on Measuring and Managing the Value of Companies

558: Founder of McKinsey's Strategy and Corporate Finance Insights Team on Measuring and Managing the Value of Companies

In this episode, Tim Koller, co-author of Valuation and a leading authority on corporate finance, offers a substantive examination of capital allocation decisions under real-world constraints. The discussion moves beyond theory to explore how CEOs and CFOs should approach resource deployment in mature, capital-rich companies—where investment opportunities are limited not due to lack of ambition but due to economic reality.

Key insights include:

- Share Buybacks as Rational Policy: Many firms undertaking significant buybacks—particularly in tech, life sciences, and consumer products—do so because they generate more cash than they can reinvest profitably. Koller argues that, in such cases, returning excess capital to shareholders is not a sign of strategic failure but of disciplined decision-making.

- The Fallacy of Diversification Without Advantage: Koller highlights repeated failures by capital-rich companies that expand into unrelated sectors to deploy cash, citing historical missteps in energy, utilities, and industrials. He emphasizes the need to assess whether the firm has a genuine competitive advantage before moving beyond its core business.

- Granular Leadership in Resource Allocation: Effective CEOs are directly engaged with capital allocation at the business-unit level. Delegating such decisions without maintaining enterprise-wide oversight often leads to underinvestment in high-return growth areas and misaligned incentives at the divisional level.

- The Perils of Uniform Cost-Cutting Mandates: Broad directives to improve margins often result in cuts to product development and customer experience—leading to long-term degradation despite short-term financial gains. Koller stresses the importance of distinguishing between cost efficiencies that enhance value and those that erode it.

- Timing and Judgment in Capital Deployment: In cyclical, capital-intensive sectors such as chemicals and energy, building capacity in sync with competitors can destroy value. Koller calls for contrarian timing, grounded in independent analysis, even when boards and markets are predisposed to follow the cycle.

Additional themes include the underuse of postmortems in capital projects, the misalignment between project planners and operators, and the distinction between executional and experimental failure. Throughout, Koller reiterates that sound capital allocation depends not only on financial modeling, but also on institutional learning, leadership judgment, and clarity of strategic intent.

This conversation offers practical, senior-level guidance for executives, board members, and investors who must navigate capital planning amid structural constraints, investor pressures, and organizational complexity.

Get Tim's book here: https://shorturl.at/nk7Z9

Valuation: Measuring and Managing the Value of Companies

Here are some free gifts for you:

Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach

McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf

Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo

Avsnitt(500)

637: Growth and Innovation at Scale, with Former IBM, Microsoft, and Salesforce Executive Jason Wild

637: Growth and Innovation at Scale, with Former IBM, Microsoft, and Salesforce Executive Jason Wild

Jason Wild discusses the discipline of building and scaling businesses through careful capital allocation, operational focus, and a clear understanding of risk. He explains how leaders often misjudge ...

18 Mars 54min

636: Dr. John La Puma on the Hidden Health Costs of Indoor Living

636: Dr. John La Puma on the Hidden Health Costs of Indoor Living

Dr. John La Puma discusses how everyday environmental choices shape sleep, cognition, and long-term health. Drawing on research from medicine, neuroscience, and environmental science, he explains why ...

16 Mars 46min

635: McKinsey Senior Partner Chris Bradley on The Real Drivers of Long-Term Economic Growth

635: McKinsey Senior Partner Chris Bradley on The Real Drivers of Long-Term Economic Growth

Chris Bradley, Senior Partner at McKinsey & Company and Director of the McKinsey Global Institute, discusses the ideas behind his book A Century of Plenty and the long-term drivers of economic growth....

11 Mars 54min

634: BCG's Julia Dhar on Why 70% of Major Change Efforts Fail

634: BCG's Julia Dhar on Why 70% of Major Change Efforts Fail

Julia Dhar, Managing Director at Boston Consulting Group and founder of the firm's Behavioral Science Lab, joins us to discuss why most organizational change efforts fail and what leaders can do diffe...

9 Mars 51min

633: The Invincible Brain with Johns Hopkins Professor Dr. Majid Fotuhi

633: The Invincible Brain with Johns Hopkins Professor Dr. Majid Fotuhi

Dr. Majid Fotuhi, neurologist, neuroscientist, and adjunct professor at Johns Hopkins University, has spent decades studying how the brain ages and what determines whether cognitive performance declin...

4 Mars 55min

632: Building Healthier Workplaces Through Attuned Leadership (with Nidhi Tewari)

632: Building Healthier Workplaces Through Attuned Leadership (with Nidhi Tewari)

Nidhi Tewari, a highly sought after wellbeing and work culture speaker who applies her experience as a licensed therapist to the work world, has spent more than a decade advising high-performing leade...

2 Mars 54min

631: How Elon Musk Thinks (with Charles Steel)

631: How Elon Musk Thinks (with Charles Steel)

Charles Steel reflects on "more than two decades in private equity, banking," combined with "public service roles, including advising Tony Blair," and how these experiences led him to a late but power...

25 Feb 52min

630: Business Innovation and Strategic Growth Advisor, Lorraine Marchand, on Sustaining Growth Through Innovation

630: Business Innovation and Strategic Growth Advisor, Lorraine Marchand, on Sustaining Growth Through Innovation

Lorraine Marchand, startup CEO, advisor to Johnson & Johnson, member of the Pharmaceutical Advisory Board at Columbia Business School, and faculty at Wharton, discusses how leaders can sustain growth ...

23 Feb 53min

Populärt inom Business & ekonomi

framgangspodden
badfluence
varvet
rss-jossan-nina
rss-svart-marknad
uppgang-och-fall
avanzapodden
rss-dagen-med-di
rss-kort-lang-analyspodden-fran-di
rss-inga-dumma-fragor-om-pengar
rss-borsens-finest
bathina-en-podcast
rss-den-nya-ekonomin
lastbilspodden
borsmorgon
market-makers
kapitalet-en-podd-om-ekonomi
fill-or-kill
rikatillsammans-om-privatekonomi-rikedom-i-livet
svd-tech-brief